🇺🇸 United States market recap
Cautious2026-06-27😱 Fear index elevated due to AI chip sell-off; investors seek safety in healthcare and lab tools.
US markets closed marginally lower Friday amid a steep drop in AI chip stocks, while healthcare surged on Moderna gains. Major M&A activity includes ON Semiconductor’s $7B all-stock deal for Synaptics and Merck’s $11B lab-tools expansion. Sentiment remains cautiously risk-on despite AI volatility, with investors pivoting toward defensive sectors. 📉🏥🔬
Big news
📰 ON Semiconductor to Buy Synaptics in All-Stock Deal With $7 Billion Enterprise Value
Boosts semiconductor sector; reinforces AI infrastructure boom despite recent chip stock volatility.
📰 Germany's Merck to Boost Lab-Tools Business With $11 Billion Acquisition
Strengthens healthcare and lab-tools sector; signals long-term confidence in biotech infrastructure.
📰 Axel Springer Agrees $766.3M Deal for UK's Telegraph Media Group
Media sector consolidation; may stabilize digital ad revenues amid shifting consumer trends.
📰 S&P 500 Ends Marginally Lower on Friday With Steep Drop in AI-Related Chip Stocks
Tech sector under pressure; investors rotate into healthcare and defensive assets.
📰 Sharp Gains in Moderna and Other Healthcare Stocks Drive Market Resilience
Healthcare sector outperforms; Moderna’s biotech breakthroughs attract defensive capital.
📰 Semiconductor Stocks Intel, Sandisk, and Lam Jump While Oracle and Adobe Drop Sharply
Mixed tech performance; chip makers rally on AI demand, software firms lag on margin concerns.
Sector stance
AI chip volatility offsets infrastructure gains; Intel, Lam, Sandisk standout names.
Moderna surge drives sector; defensive appeal amid tech uncertainty.
Media consolidation via Axel Springer-Telegraph deal; digital ad outlook mixed.
Lab-tools expansion by Merck supports industrial biotech subsector.
Weak retail sentiment; consumers prioritize essentials amid inflation fears.
Defensive positioning; stable demand for food and household goods.
Oil prices volatile; Magnolia Oil & Gas front-runner acquisition adds uncertainty.
Interest rate stability supports banks; no major M&A catalysts this week.
Merck’s lab-tools deal boosts materials subsector; limited broader impact.
High rates pressure REITs; no major property deals announced recently.
Defensive yield appeal; stable cash flows amid market volatility.
Outlook
Markets likely to stabilize as investors digest AI chip sell-off and pivot toward healthcare and staples. Interest rate expectations remain steady, limiting upside for growth stocks. Investors should overweight defensive sectors and monitor upcoming Fed data for rate signals.